Onglyza Lawsuit Alleges Diabetes Drug Caused Heart Failure In Texas Man

Print

Onglyza Lawsuit Claims Allege The Type 2 Diabetes Drug Places Patients At Risk For Heart Problems, Pancreatic Cancer, And Other Injuries.

onglyza-kombiglyze-lawsuit-Side-Effects-Lawyer-Onglyza Lawsuit Information: A Texas man suffered heart failure and respiratory failure allegedly after taking Onglyza which treats type 2 diabetes, according to an Onglyza side-effects lawsuit. Onglyza and Kombiglyze XR, brand names for the drug, saxagliptin, are at the center of lawsuits that claim the diabetes medications cause patients to develop such complications as pancreatic cancer, thyroid cancer, pancreatitis, heart failure and other health complications.

The Onglyza side-effects lawsuit states the man used saxagliptin from 2010 until 2015. As a result, the plaintiff developed heart failure, congestive heart failure, acute hypoxic respiratory failure and other serious adverse effects, the lawsuit alleges. The Onglyza lawsuit further contends that had the defendants provided adequate warnings about the adverse risk of injuries and death associated with saxagliptin, the plaintiff would not have taken the medication. The complaint names AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Company, and McKesson Corporation, which manufactures and markets Onglyza as defendants. (Case No. 4:17-cv-00316, U.S. District Court, Southern District of Texas)

“We continue to speak with men and women who believed their Onglyza and Kombiglyze XR medications were helping to control their type 2 diabetes and were not told of the serious side effects associated with the drugs,” says Attorney Richard Schulte, co-founder of Wright & Schulte LLC.

The attorneys at Wright & Schulte LLC are evaluating Onglyza and Kombiglyze XR lawsuit claims and have spoken with people who were prescribed the type 2 diabetes medications and suffered heart failure, pancreatitis, pancreatic cancer, thyroid cancer or other serious side effects. To speak with one of the firm’s attorneys, contact Wright & Schulte by visiting www.yourlegalhelp.com or call 1-888-399-0795.

Saxagliptin is a generic drug marketed as Onglyza and Kombiglyze XR. Onglyza was approved by the U.S. Food and Drug Administration (FDA) in 2009 and Kombiglyze XR (saxagliptin and metformin hydrochloride extended-release) in 2010. Onglyza and Kombiglyze are part of a class of prescription drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Along with diet and exercise, DPP-4 inhibitors lower blood sugar in adults with type 2 diabetes by inhibiting an enzyme in the body that reduces insulin production, according to the FDA. Insulin helps move sugar from the blood into the tissues so the body can use the sugar to produce energy and keep blood sugar levels stable.
[fda.gov/Drugs/DrugSafety/ucm459579.htm, FDA, August 28, 2015]

In April 2016, the FDA added heart failure warnings to the safety labels of type 2 diabetes medicines containing saxagliptin and alogliptin. The FDA urged patients taking the DPP-4 inhibitors to contact their doctors if they develop signs and symptoms of heart failure that include:

  • Unusual shortness of breath during daily activities
  • Trouble breathing when lying down
  • Tiredness, weakness or fatigue
  • Weight gain with swelling in the ankles, feet, legs or stomach

The updated safety warnings follow the FDA’s announcement in August 2015 that DDP-4 inhibitor drugs are associated with severe and disabling joint pain.
[fda.gov/Drugs/DrugSafety/ucm486096.htm, FDA, April 5, 2016]
[fda.gov/Drugs/DrugSafety/ucm459579.htm, FDA, August 28, 2015]

Onglyza and Kombiglyze XR Lawsuits are being filed nationwide alleging that AstraZenca’s type 2 diabetes drugs are associated with side-effects that include heart failure, congestive heart failure, thyroid cancer, pancreatitis and death. The complaints contend the company promotes Onglyza and Kombiglyze XR as safer than other drugs that treat type 2 diabetes without performing adequate studies on the medications. The complaints also state the company did not adequately warn that the medications increased the risk of cardiovascular-related adverse events.

About Wright & Schulte LLC And Filing An Onglyza Side Effect Lawsuits And Kombiglyze XR Side Effect Lawsuits

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Onglyza Lawsuit and Kombiglyze XR Lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.